National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 76858-76859 [2024-21419]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
76858
Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices
40. Ryan D. Maxwell, Spokane, Washington,
Court of Federal Claims No: 24–1252V
41. William Joyce, Cleveland, Ohio, Court of
Federal Claims No: 24–1254V
42. Brittany Tant, Bossier City, Louisiana,
Court of Federal Claims No: 24–1255V
43. Gregory Marks, Naples, Florida, Court of
Federal Claims No: 24–1256V
44. Claudia Burgos on behalf of B. B., Gurnee,
Illinois, Court of Federal Claims No: 24–
1257V
45. Alexander Thomas, Boston,
Massachusetts, Court of Federal Claims
No: 24–1258V
46. Zachary Clary, Bracey, Virginia, Court of
Federal Claims No: 24–1261V
47. Lori A. Brannan, Dakota Dunes, South
Dakota, Court of Federal Claims No: 24–
1262V
48. Nicole Rapson, Minneapolis, Minnesota,
Court of Federal Claims No: 24–1263V
49. Kathie Wells on behalf of C.B., Forty Fort,
Pennsylvania, Court of Federal Claims
No: 24–1264V
50. Jeanmarie Walsh, Wilmington, Delaware,
Court of Federal Claims No: 24–1268V
51. Jeffrey Arditti, Winston-Salem, North
Carolina, Court of Federal Claims No:
24–1269V
52. Shari Lovelace, Middletown, Ohio, Court
of Federal Claims No: 24–1270V
53. Jumar Busto, Los Angeles, California,
Court of Federal Claims No: 24–1271V
54. Sonja Shoemaker, Richmond Hill,
Georgia, Court of Federal Claims No: 24–
1274V
55. Valerie Albright, Dallas, Texas, Court of
Federal Claims No: 24–1277V
56. Gregory Cardona, Syosset, New York,
Court of Federal Claims No: 24–1280V
57. Michelle Hagen, Oshkosh, Wisconsin,
Court of Federal Claims No: 24–1283V
58. Kristen Sujung Han, New York, New
York, Court of Federal Claims No: 24–
1284V
59. Ava Watson, Los Angeles, California,
Court of Federal Claims No: 24–1285V
60. Kelly Pepin, Wareham, Massachusetts,
Court of Federal Claims No: 24–1286V
61. Soojin Kim, Burke, Virginia, Court of
Federal Claims No: 24–1287V
62. Annie Bergenheier on behalf of D.B.,
Wichita Falls, Texas, Court of Federal
Claims No: 24–1288V
63. Cathy Ann Kallman, Carson City, Nevada,
Court of Federal Claims No: 24–1289V
64. Richard Imlay, Roseville, Michigan, Court
of Federal Claims No: 24–1291V
65. Nicole Haymon, Culver City, California,
Court of Federal Claims No: 24–1292V
66. Tannista Banerjee, Peachtree City,
Georgia, Court of Federal Claims No: 24–
1293V
67. Jeremy Cochran, Arden, North Carolina,
Court of Federal Claims No: 24–1294V
68. Carmen Alfaro Balcaceres, Baltimore,
Maryland, Court of Federal Claims No:
24–1295V
69. Laura Watts, Elizabethtown, Kentucky,
Court of Federal Claims No: 24–1297V
70. Gabrielle Ronn, New York, New York,
Court of Federal Claims No: 24–1298V
71. Veronica E. Johnson, Jamaica, New York,
Court of Federal Claims No: 24–1299V
72. Sohui Lee, Chicago, Illinois, Court of
Federal Claims No: 24–1302V
VerDate Sep<11>2014
16:59 Sep 18, 2024
Jkt 262001
73. Lisa Gulcher, Washington, District of
Columbia, Court of Federal Claims No:
24–1306V
74. Pammie Kurth, Green Bay, Wisconsin,
Court of Federal Claims No: 24–1307V
75. Lorraine Dugan, Leesburg, Virginia, Court
of Federal Claims No: 24–1309V
76. Linda M. Miller, Fuquay Varina, North
Carolina, Court of Federal Claims No:
24–1311V
77. Bryan Bower, Olean, New York, Court of
Federal Claims No: 24–1312V
78. Jace Bundy, Chicago, Illinois, Court of
Federal Claims No: 24–1317V
79. Jacklyn Bennison, Asheville, North
Carolina, Court of Federal Claims No:
24–1318V
80. Ann Heiden, Edgerton, Wisconsin, Court
of Federal Claims No: 24–1319V
81. Michael McRae, Sussex, New Jersey,
Court of Federal Claims No: 24–1321V
82. Joseph Franke, Albuquerque, New
Mexico, Court of Federal Claims No: 24–
1323V
83. Linda Radding, Vancouver, Washington,
Court of Federal Claims No: 24–1324V
84. Lori Benjamin, Granger, Indiana, Court of
Federal Claims No: 24–1325V
85. Claudia Hernandez, Diamond Bar,
California, Court of Federal Claims No:
24–1326V
86. Rachael Tamara Vasquez, Stockton,
California, Court of Federal Claims No:
24–1327V
87. Kipp Mickles, Apple Valley, California,
Court of Federal Claims No: 24–1328V
88. Francis McKenna, Palm Bay, Florida,
Court of Federal Claims No: 24–1329V
89. Josephine Trawick, Odenton, Maryland,
Court of Federal Claims No: 24–1330V
90. Cristina Novoa, Miami, Florida, Court of
Federal Claims No: 24–1331V
91. Jeffrey Allensworth, Lenexa, Kansas,
Court of Federal Claims No: 24–1336V
92. Davee Davis, Washington, District of
Columbia, Court of Federal Claims No:
24–1338V
93. Sonja D. White, Englewood, Ohio, Court
of Federal Claims No: 24–1339V
94. Charlotte Mesimore, Chicago, Illinois,
Court of Federal Claims No: 24–1340V
95. Gregory Reilly on behalf of L.R.,
Springfield, Pennsylvania, Court of
Federal Claims No: 24–1341V
96. Benjamin Gleason, Tacoma, Washington,
Court of Federal Claims No: 24–1343V
97. Sean Booker, East Providence, Rhode
Island, Court of Federal Claims No: 24–
1344V
98. Naomi Rawitz, Ann Arbor, Michigan,
Court of Federal Claims No: 24–1346V
99. Bethany Barry, Boston, Massachusetts,
Court of Federal Claims No: 24–1348V
100. Leon Gulley, Cincinnati, Ohio, Court of
Federal Claims No: 24–1350V
101. Eliza Shumway, Lindon, Utah, Court of
Federal Claims No: 24–1354V
102. Thomas Van Horn, Jr., Springfield,
Pennsylvania, Court of Federal Claims
No: 24–1356V
103. David Ormsbee, Apopka, Florida, Court
of Federal Claims No: 24–1358V
[FR Doc. 2024–21434 Filed 9–18–24; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Cancellation of Meeting
Notice is hereby given of the
cancellation of the National Asthma
Education Prevention Program
Coordinating Committee, September 23,
2024, 11:00 a.m. to September 23, 2024,
1:00 p.m., National Institutes of Health,
6100 Executive Boulevard, Rockville,
MD 20852 which was published in the
Federal Register on July 30, 2024, 89 FR
61131.
The meeting is being postponed to a
later date. A new Federal Register
Notice will be posted once a new date
has been set.
Dated: September 13, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21388 Filed 9–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK25–008:
Diabetes Research Centers (P30 Clinical Trial
Optional).
Date: November 13–14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, National Institute of Diabetes
E:\FR\FM\19SEN1.SGM
19SEN1
Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Bethesda, MD 20892, (301) 496–
7050, lan.tian@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21419 Filed 9–18–24; 8:45 am]
Dated: September 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–21416 Filed 9–18–24; 8:45 am]
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–23–011:
CKM for the Safe Use of SGLT2i in T1D.
Date: October 29, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Lan Tian, Ph.D., Scientific
Review Officer, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Bethesda, MD 20892, (301) 496–
7050, lan.tian@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
VerDate Sep<11>2014
16:59 Sep 18, 2024
Jkt 262001
76859
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR 22–069 High
Impact, Interdisciplinary Science in NIDDK
Research Areas (RC2).
Date: November 15, 2024.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Tori Stone, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney,
National Institute of Health, 6707 Democracy
Boulevard, Bethesda, MD 20892, (301) 827–
0994, tori.stone@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21421 Filed 9–18–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders C Study Section.
Date: October 15–16, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ana Olariu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
INDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–496–
9223, Ana.Olariu@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; DMFP Contract Proposal
Review Meeting.
Date: October 18, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Surojeet Sengupta, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–496–
9223, surojeet.sengupta@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NSD–C Member Conflict.
Date: October 31, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
E:\FR\FM\19SEN1.SGM
19SEN1
]]>Agencies
[Federal Register Volume 89, Number 182 (Thursday, September 19, 2024)]
[Notices]
[Pages 76858-76859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21419]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA-DK25-008: Diabetes
Research Centers (P30 Clinical Trial Optional).
Date: November 13-14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Lan Tian, Ph.D., Scientific Review Officer,
National Institute of Diabetes
[[Page 76859]]
and Digestive and Kidney Diseases, National Institutes of Health,
6707 Democracy Boulevard, Bethesda, MD 20892, (301) 496-7050,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: September 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21419 Filed 9-18-24; 8:45 am]
BILLING CODE 4140-01-P
